AI in healthcare: key highlights in 2021
In common with virtually every other sector, the healthcare industry is being steadily transformed by artificial intelligence (AI) and machine…
All articles by Chris Lo
Chris Lo
-
-
Coronavirus company news summary – UK to start rolling out Merck’s molnupiravir through trial – NRx plans vaccine production facility in Luxembourg
The UK is set to commence the rollout of Merck’s antiviral pill, molnupiravir, for Covid-19 through a trial by the…
-
Coronavirus company news summary – FDA denies EUA to NRx’s Zyesami for critical Covid-19 – AZ will not pursue approval of its Covid-19 vaccine in Switzerland
The US Food and Drug Administration (FDA) has denied emergency use authorization (EUA) to NRx Pharmaceuticals’ Zyesami (aviptadil) for the…
-
Coronavirus company news summary – Lilly to supply more doses of antibody cocktail to US in $1.29bn deal – NRx reports positive safety data in Phase III trial of Covid-19 treatment
Eli Lilly has signed an agreement to supply additional doses of its Covid-19 combination therapy, bamlanivimab with etesevimab, to the…
-
Coronavirus company news summary – Indonesia grants emergency approval to Novavax vaccine – Resverlogix in talks to start Covid-19 treatment trial in Morocco
The National Agency of Drug and Food Control of the Republic of Indonesia has granted Emergency Use Authorization (EUA) to…
-
Coronavirus company news summary – FDA grants emergency approval to Pfizer/BioNTech shot in children aged 5-11, extends review of Moderna’s jab in adolescents
The US Food and Drug Administration (FDA) has granted Emergency Use Authorisation to Pfizer and BioNTech’s Covid-19 vaccine for children…
-
Global warning: pharma’s role in the climate crisis
Despite the distrust with which the pharma industry tends to be viewed by the general public, it remains an industry…
-
Coronavirus company news summary – US buys 50 million Pfizer vaccine doses for paediatric use – ARCA to proceed with Phase IIb trial of severe Covid-19 treatment
The US government has bought 50 million additional doses of Pfizer-BioNTech’s Covid-19 vaccine. These doses will aid in boosting readiness for…
-
Coronavirus company news summary – CDC committee to discuss Covid-19 vaccines in young children – Merck signs molnupiravir licensing deal with Medicines Patent Pool to increase generic production
The advisory committee of the US Centers for Disease Control and Prevention will convene a meeting on 2 November to…
-
Coronavirus company news summary – FDA panel recommends EUA expansion for Pfizer/BioNTech jab in children aged five to 12 – Vaxart begins world-first Phase II trial of Covid-19 oral tablet vaccine
The Vaccines and Related Biological Products Advisory Committee (VRBPAC) of the US Food and Drug Administration (FDA) has recommended granting…